1. Risk of Atrial Fibrillation, Ischemic Stroke and Cognitive Impairment: Study of a Population Cohort ≥65 Years of Age
  2. Incidence and Risk Assessment for Atrial Fibrillation at 5 Years: Hypertensive Diabetic Retrospective Cohort
  3. Results, barriers and enablers in atrial fibrillation case finding: barriers in opportunistic atrial fibrillation case finding—a cross-sectional study
  4. N-Terminal Pro B-Type Natriuretic Peptide’s Usefulness for Paroxysmal Atrial Fibrillation Detection Among Populations Carrying Cardiovascular Risk Factors
  5. Risk of Long-Term Mortality for Complex Chronic Patients with Intracerebral Hemorrhage: A Population-Based e-Cohort Observational Study
  6. Cardioembolic Ischemic Stroke Gene Expression Fingerprint in Blood: a Systematic Review and Verification Analysis
  7. Risk of Dependency: A Challenge for Health and Social Care Planning-Observational Stroke Cohort
  8. Atrial Fibrillation and Cognitive Impairment: A Growing Association. Occurrence of Death among Chronic Complex Outpatients
  9. Complex Chronic Patients and Atrial Fibrillation: Association with Cognitive Deterioration and Heart Failure
  10. Longterm Mortality among Chronic Complex Patients with polypharmacy: Results of Community- Based Prospective Study
  11. International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER)
  12. Long-Term Survival After Stroke According to Reperfusion Therapy, Cardiovascular Therapy and Gender
  13. Mortality in heart failure with atrial fibrillation: Role of digoxin and diuretics
  14. Mortality and Cardiovascular Complications in Older Complex Chronic Patients with Type 2 Diabetes
  15. Incidence and preventability of haemorrhagic strokes. Results of the Ebrictus register
  16. Sex Differences in Long-Term Survival after a First Stroke with Intravenous Thrombolysis: Ebrictus Study
  17. Results from the Registry of Atrial Fibrillation (AFABE): Gap between Undiagnosed and Registered Atrial Fibrillation in Adults–Ineffectiveness of Oral Anticoagulation Treatment with VKA
  18. Differences in the survival after an episode of stroke treated with thrombolytic therapy. Study Ebrictus
  19. Prevalence of undiagnosed atrial fibrillation and of that not being treated with anticoagulant drugs: the AFABE study
  20. Atrial Fibrillation and Cardiovascular Comorbidities, Survival and Mortality: A Real-Life Observational Study
  21. The management of atrial fibrillation and characteristics of its current care in outpatients. AFABE observational study
  22. Primary and secondary cardiovascular prevention results in patients with stroke: relapse risk and associated survival (Ebrictus study)
  23. The stroke care system in Terres de l’Ebre, Spain, after the implementation of the Stroke Code model: Ebrictus Study
  24. Ebrictus study. Functional results, survival, and potential years of life lost after the first stroke
  25. Diabetes and hypertension: a growing and costly epidemic
  26. Characteristics of oral anti-coagulation treatment in high-risk chronic auricular fibrillation
  27. Conceming «From self management to clinical management»
  28. Cost-effectiveness analysis of self-monitoring of blood glucose in type 2 diabetics
  29. Blood glucose self-monitoring (BGSM): an evaluation of its prescription and results in type-2 diabetes. The Research Group in Primary Care of Tortosa
  30. The evaluation of the self-financing capacity within the territorial compass of a primary care management
  31. The quality of professional life and the pride in working in public health. The results of a survey
  32. Evaluation of the effectiveness of metabolic self-control through direct dispensation of diagnostic strips to type 2 diabetic patients
  33. Use of the resources in the diagnosis and control of diabetes mellitus in a rural area